Evidence map›Paper›PMID 8649385›Full record

ArticleMolecular and cellular biology1996

Signals sufficient for 3'-end formation of yeast mRNA.

Z Guo, F Sherman

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Development of Terminator-Promoter Bifunctional Elements for Application inInternational journal of molecular sciences · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Biology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Z GuoDepartment of Biochemistry, University of Rochester School of Medicine and Dentistry, New York 14642, USA.
F Sherman
University of Rochester · US

Funding

Regulation and Gene Expression of Yeast Cytochrome cR01GM012702 · NIGMS · UNIVERSITY OF ROCHESTER · PI SHERMAN, FRED · 1985 to 2010
$4.3M
NIGMS NIH HHS R01 GM12702
6 · The paper itself

Abstract

The following three elements were previously shown to be required for 3'-end formation of mRNA in the yeast Saccharomyces cerevisiae: (i) the efficiency element TATATA or related sequences, which function by enhancing the efficiency of downstream positioning elements; (ii) the positioning element AATAAA or related sequences, which position the poly(A) site; and (iii) the actual poly(A) site, which is usually Py(A)n. In this study, we synthesized a 39-pb poly(A) signal that contained the optimum sequences of these three elements. By inserting the synthetic 3'-end-forming signal into various positions of a CYC1-lacZ fusion gene, we showed that truncated transcripts of the expected sizes were generated. Furthermore, the poly(A) sites of the truncated transcripts were mapped to the expected poly(A) site within the synthetic signal. Our findings establish that the three elements are not only necessary but also sufficient for mRNA 3'-end formation in S. cerevisiae.

Indexed as

Cytochromes cSaccharomyces cerevisiae ProteinsBase SequenceCloning, MolecularCytochrome c GroupGenes, FungalLac OperonMolecular Sequence DataPoly ARNA, FungalRNA, MessengerSaccharomyces cerevisiaeSignal TransductionCYC1 protein, S cerevisiaeCytochrome c GroupCytochromes cPoly ARNA, FungalRNA, MessengerSaccharomyces cerevisiae Proteins

Identifiers

PMID8649385
PMCPMC231268
OpenAlexW2103480408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.